Wegovy Availability & UK Clinical Results | Cured

Clinically Proven UK Registered Pharmacy

Wegovy Availability & UK Clinical Weight Loss Results

UK-registered clinical team
Confidential and secure
No GP visit needed
Fast and discreet delivery
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £10 off for new customers
Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment
£89.00 From £79.00 £10 discount using discount code Weightlossnew
LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £135.00

£36.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £169.00

£44.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £210.00

£55.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £235.00

£61.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £260.00

£67.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £277.00

£71.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £79.00

£22.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £99.00

£27.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £109.00

£29.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £159.00

£42.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £189.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation

Wegovy Availability & UK Clinical Weight Loss Results

Searching for accurate information on wegovy availability uk clinical results? Wegovy (semaglutide) is now consistently available at Cured Pharmacy from £79.00, following previous UK supply shortages. Clinical trial data demonstrates substantial weight loss outcomes when combined with lifestyle modifications, and our UK-registered prescribers can assess your suitability within minutes.

Current Wegovy Availability UK Status

Wegovy experienced significant supply constraints across the UK throughout 2022 and 2023 due to unprecedented global demand. The MHRA and manufacturer Novo Nordisk have since stabilised production, and Wegovy is now consistently available through registered UK pharmacies including Cured Pharmacy [1].

At Cured Pharmacy, we maintain regular stock of all Wegovy dose strengths (0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg). Our transparent pricing model shows costs upfront — from £79.00 per pen — before you complete your free clinical consultation. All prescriptions are issued by UK-registered prescribers following a thorough online assessment, typically completed in under three minutes.

Wegovy Clinical Trial Results: STEP Programme Data

The STEP (Semaglutide Treatment Effect in People with obesity) clinical trial programme provides the most comprehensive evidence for Wegovy's efficacy. In the landmark STEP 1 trial, adults with obesity who received once-weekly semaglutide 2.4mg achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [2].

STEP 2 specifically examined patients with type 2 diabetes, demonstrating an average weight loss of 9.6% alongside improved glycaemic control [3]. Notably, 86.4% of participants in STEP 1 achieved at least 5% weight loss — the threshold associated with significant cardiometabolic health improvements — whilst 69.1% achieved 10% or greater weight reduction [2].

Long-Term Weight Maintenance Results

The STEP 4 trial examined weight maintenance after initial treatment. Participants who continued semaglutide maintained an average total weight loss of 17.4% from baseline at week 68, whilst those switched to placebo regained 6.9% [4]. This data suggests Wegovy supports sustained weight management when treatment continues alongside lifestyle modifications, subject to ongoing prescriber review.

How Wegovy Works: Semaglutide Mechanism

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a naturally occurring hormone in your body. GLP-1 regulates appetite by acting on areas of the brain that control hunger signals, whilst also slowing gastric emptying to promote feelings of fullness [1].

Unlike older weight loss medications that work peripherally, semaglutide's central nervous system effects produce substantial appetite reduction. In clinical trials, participants reported decreased food cravings and reduced preoccupation with food — effects that contributed to the significant caloric deficit necessary for weight loss [2]. The once-weekly injection schedule improves adherence compared to daily treatments.

Treatment Active Ingredient Injection Frequency Average Weight Loss Starting Price
Wegovy Semaglutide 2.4mg Once weekly 14.9% at 68 weeks From £89.00
Saxenda Liraglutide 3mg Daily 8% at 56 weeks From £68.00
Mounjaro Tirzepatide Once weekly Up to 22.5% at 72 weeks From £145.00

Wegovy Dosing Schedule and Treatment Timeline

Wegovy follows a gradual dose escalation protocol designed to minimise gastrointestinal side effects whilst optimising efficacy. Treatment begins at 0.25mg weekly for four weeks, then increases monthly through 0.5mg, 1mg, and 1.7mg, reaching the maintenance dose of 2.4mg by week 17 [1].

Clinical trial data shows most weight loss occurs during the first 60 weeks of treatment, with participants continuing to lose weight throughout this period when adherent to the prescribed regimen [2]. Your UK prescriber will monitor your progress and may adjust the escalation schedule if you experience tolerability issues. All dose changes require prescriber approval and cannot be self-adjusted.

What to Expect During Treatment

Most patients notice reduced appetite within the first few weeks of treatment, though maximum weight loss typically occurs gradually over 12-16 months. The STEP trials demonstrated that weight loss continues throughout the dose escalation phase and plateaus around week 60-68 [2]. Combining Wegovy with a reduced-calorie diet and increased physical activity produces optimal results, as demonstrated across all STEP trials.

Common Side Effects and Management Strategies

The most frequently reported side effects in STEP trials were gastrointestinal: nausea (44% vs 16% placebo), diarrhoea (31% vs 16%), vomiting (24% vs 6%), and constipation (24% vs 11%) [2]. These effects were predominantly mild to moderate in severity and typically diminished over time as patients adjusted to treatment.

Our clinical team at Cured Pharmacy, led by superintendent pharmacist Tarun Kumar (GPhC 2233073), recommends several strategies to minimise side effects: eat smaller, more frequent meals; avoid high-fat foods; stay well-hydrated; and inject at consistent times. Most gastrointestinal symptoms resolve within 4-8 weeks. If side effects persist or worsen, contact your prescriber immediately — they may recommend slowing dose escalation or temporarily maintaining your current dose.

When to Seek Medical Advice

Discontinue Wegovy and seek immediate medical attention if you experience symptoms of pancreatitis (severe abdominal pain radiating to your back), signs of thyroid tumours (lump in neck, hoarseness, difficulty swallowing), or severe allergic reactions. Whilst rare, these serious adverse events were monitored throughout clinical trials [1]. Your prescriber will assess your individual risk factors during consultation, and Wegovy is contraindicated in patients with personal or family history of medullary thyroid carcinoma.

Wegovy Availability UK: Ordering from Cured Pharmacy

Ordering Wegovy through Cured Pharmacy is straightforward and fully compliant with UK regulations. Begin by completing our free online clinical assessment, which takes under three minutes and covers your medical history, current medications, and weight loss goals. A UK-registered prescriber reviews your assessment, typically within hours, and issues a prescription if clinically appropriate.

Once approved, your Wegovy prescription is dispensed by our GPhC-registered pharmacy (9012511) and dispatched in 100% discreet packaging. We offer competitive pricing with full transparency — you'll see the exact cost before completing your consultation. Our UK clinical team remains available at (+44) 116 4646009 for any questions throughout your treatment journey. All medications are genuine UK-licensed products sourced through regulated supply chains, never grey imports.

Scientific References

  1. Electronic Medicines Compendium. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Medicines and Healthcare products Regulatory Agency. https://www.medicines.org.uk/emc/product/13799
  2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
  3. Davies, M., Færch, L., Jeppesen, O. K., et al. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971–984. https://doi.org/10.1016/S0140-6736(21)00213-0
  4. Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to prescribed treatment alongside diet and exercise modifications.

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Is Wegovy available in the UK now?
Yes, Wegovy is now consistently available through UK-registered pharmacies including Cured Pharmacy following previous supply shortages. All doses are in stock and available from £79.00 subject to prescriber approval.
What are the clinical results for Wegovy in UK trials?
The STEP clinical trials showed participants achieved an average 14.9% body weight reduction over 68 weeks, with 86.4% achieving at least 5% weight loss and 69.1% achieving 10% or greater reduction.
How much weight can I expect to lose on Wegovy?
Clinical trial participants lost an average of 14.9% of their starting body weight over 68 weeks when combining Wegovy with lifestyle modifications. Individual results vary based on adherence, diet, and physical activity levels.
Do I need a prescription for Wegovy in the UK?
Yes, Wegovy is a prescription-only medication in the UK. At Cured Pharmacy, a UK-registered prescriber will assess your suitability through a free online consultation before issuing a prescription if clinically appropriate.
How long does Wegovy take to work for weight loss?
Most patients notice reduced appetite within 2-4 weeks, though significant weight loss typically becomes evident after 12-16 weeks. Maximum weight loss occurs around week 60-68 of continuous treatment.
What's the difference between Wegovy and Ozempic?
Both contain semaglutide, but Wegovy is licensed specifically for weight management at a 2.4mg maintenance dose, whilst Ozempic is licensed for type 2 diabetes at lower doses (0.5mg-1mg). They should not be used interchangeably without prescriber guidance.
Can I buy Wegovy online from Cured Pharmacy?
Yes, you can order Wegovy online from Cured Pharmacy after completing a free clinical assessment. A UK prescriber reviews your submission and issues a prescription if suitable, then we dispense and deliver discreetly to your address.
Are there any wegovy availability uk clinical results for NHS patients?
NICE has recommended Wegovy for NHS use in specific circumstances, though availability varies by ICB. The clinical results referenced are from international STEP trials, which inform UK prescribing decisions across both NHS and private sectors.